Medical Device Company Intelligence Reports provide a full review of the company's activities, from its origins to its latest corporate activity, including mergers and acquisitions, agreements, divestitures, major purchasing contracts and litigation. Sections are included on products, international activities and R&D, as well as a full, in-depth five year financial analysis. An introduction to each report and a full table of contents is provided for review. More than 60 Medical Device Company Intelligence Reports are currently available.

Coloplast, headquartered in Humlebaek, Denmark, develops, manufactures and markets ostomy devices, urology products, continence care devices, wound care and skin care products. This report provides a full review of the company's activities.

Coloplast develops and manufactures ostomy devices, urology products, continence care devices, wound care and skin care products. In June 2006, the company purchased Mentor's urology unit, which enabled it to expand its existing continence care portfolio and gain new products that address general and surgical urology. This acquisition also moved Coloplast to the leading position in the urology and continence care market segments in which it participates. Through the acquisition, Coloplast also gained Mills Biopharmaceuticals, Mentor's brachytherapy division, which it sold to Core Oncology in June 2007.

In April 2007, Coloplast sold its Breast Care unit, which manufactured external breast forms and post-mastectomy lingerie and swimwear, as part of its strategy to focus on its Ostomy Care, Urology and Continence Care, and Wound and Skin Care units. To further enhance its urology portfolio, Coloplast acquired assets related to the Levera Male Incontinence Therapy - a sling therapy designed to address symptoms of male stress urinary incontinence (SUI) - from Caldera Medical in November 2007.

In fiscal 2008, the company began production at new factories in Zhuhai, China and Nyírbátor, Hungary. By the end of 2011, the number of production facilities in Denmark will be reduced to two from the original six.

Coloplast markets and sells its products and services globally. The majority of its revenue is generated in Europe, which accounted for 77% of the company's DKr8,820 million of total sales in fiscal 2009. In June 2009, the company opened its new US headquarters in Minneapolis, Minnesota, which signalled the company's commitment to focus growth initiatives on the US marketplace. At the end of September 2009, Coloplast employed more than 7,000 people.

Coloplast's major shareholders are members of the Louis-Hansen family, which hold approximately 31% of the share capital and 55% of the votes in Coloplast.

This company report provides
Overview
- Key contact information
- Introduction to the company and its current activities
- Summary of its financial performance
- Who are the company's major competitors?
- Key recent events in an ""at a glance"" format
Financial Review
- Current year and annual financial data, including revenue breakdowns by product area and geographic region (if available)
- Table providing in-depth five-year financial analysis
- Employee data, including breakdown by company division and geographic location
Strategic Focus
- Investigates the company's aims and its areas of focus
Products
- Core product areas, key brands, product approvals and launches
Research and Development
- How much has been invested in R&D?
- Where is the research based?
- What alliances and agreements does the company have and with whom?
Manufacturing and Distribution
- Identifying the company's manufacturing locations
- Sales and marketing facilities
Agreements
- With whom has the company reached agreements and what do they involve?
- Key contracts awarded
Mergers, Acquisitions, Minority Investments and Divestments
Key Corporate Events

Summary Operating Results
Overview
- Recent Key Events
Financial Review
- Fiscal 2009 Financial Results
- Coloplast - Annual Financial Results, Fiscal Years 2005-2009
- Coloplast - Annual Sales and Operating Income, Fiscal Years 2005-2009
- Coloplast - Annual Sales by Business Segment, Fiscal Years 2006-2009
- Coloplast - Annual Sales by Business Segment, Fiscal Years 2006-2009
- Coloplast - Annual Sales by Geographic Area, Fiscal Years 2006-2009
- Coloplast - Annual Sales by Geographic Area, Fiscal Years 2006-2009
- Five-Year Financial Data
- Coloplast - Five-Year Financial Summary, Fiscal Years 2005-2009
- Outlook
- Employees
- Coloplast - Employees
Strategic Focus
Products
- Ostomy Care
- Ostomy Care Market
- Closed Bags
- Closed Bag Product Types
- Drainable Bags
- Drainable Bag Product Types
- Urostomy Bags
- Urostomy Bag Product Types
- Paediatric O Stomy
- Hernia S Upport
- Fistula & Wound Management S Ystem
- Irrigation S Ystems
- Urology and Continence Care
- Continence Care Market
- Urology Market
- Catheters
- Urine Bags
- Urisheaths
- Bowel Management
- Penile Implants
- Wound and Skin Care
- Share of Moist Wound Healing Market, Europe and US
Research and Development
- Coloplast - Annual R&D Expenses
Manufacturing
- Coloplast - Manufacturing Facilities, September 2009
- Coloplast - Transfer of Production
Agreements
- Agreements Summary
- Smith & Nephew
- Johnson & Johnson
- ©espicom Business December 2009 Intelligence
- Coloplast Table of Contents
- Caldera Medical
- Carbon Medical T Echnologies
- Tutogen Medical (Now Rti Biologics)
- Rochester Medical
- Mckesson
Mergers and Acquisitions
- Mergers and Acquisitions Summary
- Levera Male Incontinence T Herapy
- Mentor's Urology Division
- Amoena
- Ssl International's Continence Care Business
- Home S Upply & Care
- Co-Inject
- Sween
Minority Investments
- Interface Biotech
- Nordic Vaccine T Echnology
Divest Itures
- Mills Biopharmaceuticals
- Breast Care Division
- Sterling Medical S Ervices
- Contrelle
- Aviana Brand
- Consumer P Roducts Division
- Hsc's Nutrition Business
Key Corporateevents
Index of Tables
- Summary Operating Results
- Recent Key Events
- Coloplast - Annual Financial Results, Fiscal Years 2005-2009
- Coloplast - Annual Sales by Business Segment, Fiscal Years 2006-2009
- Coloplast - Annual Sales by Geographic Area, Fiscal Years 2006-2009
- Coloplast - Five-Year Financial Summary, Fiscal Years 2005-2009
- Coloplast - Employees
- Coloplast - Annual R&D Expenses
- Coloplast - Manufacturing Facilities, September 2009
- Agreements Summary
- Mergers and Acquisitions Summary
Index of Charts
- Coloplast - Annual Sales and Operating Income, Fiscal Years 2005-2009
- Coloplast - Annual Sales by Business Segment, Fiscal Years 2006-2009
- Coloplast - Annual Sales by Geographic Area, Fiscal Years 2006-2009
- Ostomy Care Market
- Continence Care Market
- Urology Market
- Share of Moist Wound Healing Market, Europe and US
- Coloplast - Transfer of Production

Pharmaceutical Market Research

Coloplast Medical Device Company Intelligence Report

Coloplast Medical Device Company Intelligence Report

Contents

Related products